| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |